UPDATE 1-Valeant to sell Dendreon unit to China's Sanpower for $820 mln

Jan 9 (Reuters) - Canada's Valeant Pharmaceuticals

International Inc said its affiliate will sell its

Dendreon cancer business to China's Sanpower Group Co Ltd

for $819.9 million, as the drugmaker...

Read more